Prevention of Docetaxel Induced Dacryostenosis

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2009

Conditions

Epiphora

Interventions

DRUG

Maxidex; Lacrystat

6 times daily, for 20 weeks.

Trial Locations (1)

Mombaerts, Leuven

All Listed Sponsors

lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT00266838 - Prevention of Docetaxel Induced Dacryostenosis | Biotech Hunter | Biotech Hunter